We are live on ! Find out more
AT

Argent Trust Portfolio holdings

AUM $365M
1-Year Est. Return 9.78%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+9.78%
3 Year Est. Return
+25.75%
5 Year Est. Return
10 Year Est. Return
AUM
$353M
AUM Growth
+$9.14M
Cap. Flow
-$604K
Cap. Flow %
-0.17%
Top 10 Hldgs %
27.52%
Holding
210
New
10
Increased
87
Reduced
83
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 15.06%
2 Energy 14.81%
3 Industrials 14.16%
4 Financials 13.98%
5 Technology 12.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
26
Bank of America
BAC
$430B
$3.61M 1.02%
152,988
+10,485
+7% +$249K
MCD icon
27
McDonald's
MCD
$190B
$3.56M 1.01%
27,497
-1,300
-5% -$163K
ABBV icon
28
AbbVie
ABBV
$450B
$3.5M 0.99%
53,768
+853
+2% +$53.6K
DIS icon
29
Walt Disney
DIS
$170B
$3.4M 0.96%
29,942
+437
+1% +$48.1K
SCI icon
30
Service Corp International
SCI
$10.9B
$3.37M 0.95%
108,991
+803
+0.7% +$24.2K
AXP icon
31
American Express
AXP
$242B
$3.33M 0.94%
42,028
-1,393
-3% -$109K
V icon
32
Visa
V
$682B
$3.16M 0.9%
35,574
+1,337
+4% +$115K
CFR icon
33
Cullen/Frost Bankers
CFR
$10.2B
$3.12M 0.88%
35,082
+210
+0.6% +$18.9K
WMT icon
34
Walmart Inc
WMT
$909B
$3.08M 0.87%
128,205
-2,208
-2% -$50.8K
MKC icon
35
McCormick & Company Non-Voting
MKC
$13.9B
$3M 0.85%
61,584
-826
-1% -$40K
ITW icon
36
Illinois Tool Works
ITW
$79.4B
$2.97M 0.84%
22,415
-727
-3% -$94K
BMY icon
37
Bristol-Myers Squibb
BMY
$124B
$2.96M 0.84%
54,428
+969
+2% +$53.1K
WBA
38
DELISTED
Walgreens Boots Alliance
WBA
$2.72M 0.77%
32,729
-700
-2% -$58.7K
CVS icon
39
CVS Health
CVS
$137B
$2.66M 0.75%
33,861
-324
-0.9% -$25.9K
DGX icon
40
Quest Diagnostics
DGX
$23.3B
$2.48M 0.7%
25,202
-400
-2% -$38.1K
USB icon
41
US Bancorp
USB
$98.4B
$2.46M 0.7%
47,820
-4,108
-8% -$219K
RTX icon
42
RTX Corp
RTX
$261B
$2.45M 0.69%
34,699
+103
+0.3% +$7.23K
CMCSA icon
43
Comcast
CMCSA
$85B
$2.4M 0.68%
63,818
-1,600
-2% -$59.4K
C icon
44
Citigroup
C
$217B
$2.37M 0.67%
39,647
+90
+0.2% +$5.32K
GILD icon
45
Gilead Sciences
GILD
$167B
$2.35M 0.66%
34,525
+2,215
+7% +$156K
ORCL icon
46
Oracle
ORCL
$364B
$2.29M 0.65%
51,429
-2,071
-4% -$86.2K
CELG
47
DELISTED
Celgene Corp
CELG
$2.21M 0.63%
17,741
+606
+4% +$72.5K
HAL icon
48
Halliburton
HAL
$29.4B
$2.2M 0.62%
44,670
-378
-0.8% -$20.3K
ETR icon
49
Entergy
ETR
$52.8B
$2.19M 0.62%
57,736
-1,838
-3% -$67.4K
FDX icon
50
FedEx
FDX
$74.7B
$2.19M 0.62%
11,211
-212
-2% -$40.5K

Similar funds

Argent Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Argent Trust held 210 positions worth $353M, up 2.7% from $344M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Argent Trust's Q1 2017 filing shows 10 new, 87 increased, 83 reduced and 9 closed positions. Its largest new stake was AstraZeneca: 6,074 shares worth $378K. The largest sale was Norfolk Southern, an estimated $1.26M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Energy and Industrials.

  • Argent Trust's largest Q1 2017 buy was AstraZeneca: 6,074 shares worth $378K.
  • Argent Trust added most to Thermo Fisher Scientific in Q1 2017, an estimated $643K increase.
  • Argent Trust's biggest Q1 2017 reduction was Norfolk Southern, cutting an estimated $1.26M.
  • Argent Trust fully exited PNC Financial Services in Q1 2017, selling an estimated $677K.
  • Argent Trust's ten largest holdings make up 28% of its $353M portfolio in Q1 2017.
  • Argent Trust opened 10 new positions and closed 9 in Q1 2017.
  • Argent Trust's portfolio value rose 2.7% quarter-over-quarter to $353M.

Based on Argent Trust's 13F filing for Q1 2017, filed 10 May 2017.